Use of Saccharomyces cerevisiae ERG4 mutants for the expression of glucose transporters from mammals
Details for Australian Patent Application No. 2003264257 (hide)
International Classifications
Event Publications
11 December 2003 Complete Application Filed
Priority application(s): 102 42 763.1 14.09.02 DE
20 May 2004 Application Open to Public Inspection
Published as AU-B-2003264257
22 December 2005 Assignment before Grant
Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH
20 May 2010 Application Accepted
Published as AU-B-2003264257
16 September 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003264256-A NUTRITIONAL AND THERAPEUTIC COMPOSITION OF AN INSULIN SENSITIZER AND A PEPTIDE FRACTION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser